We are live on ! Find out more
MRVI icon

Maravai LifeSciences
MRVI

144 hedge funds and large institutions have $3.51B invested in Maravai LifeSciences in 2021 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 41 increasing their positions, 34 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 30

28% more capital invested

Capital invested by funds: $2.73B → $3.51B (+$778M)

22% more funds holding

Funds holding: 118 → 144 (+26)

21% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 34

0.97% more ownership

Funds ownership: 100.83% → 101.8% (+0.97%)

31% less call options, than puts

Call options by funds: $2.29M | Put options by funds: $3.34M

40% less funds holding in top 10

Funds holding in top 10: 5 → 3 (-2)

Holders
144
Holders Change
+26
Holders Change %
+22.03%
% of All Funds
2.53%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.05%
New
56
Increased
41
Reduced
34
Closed
30
Calls
$2.29M
Puts
$3.34M
Net Calls
-$1.05M
Net Calls Change
-$5.93M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$132M
2
Select Equity Group
Select Equity Group
New York
+$132M
3
CIP
Champlain Investment Partners
Vermont
+$56.6M
4
Morgan Stanley
Morgan Stanley
New York
+$45.8M
5
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$38M

Top Sellers

Rank Fund Capital Flow
1
DCP
D1 Capital Partners
New York
-$166M
2
Holocene Advisors
Holocene Advisors
New York
-$39.8M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$31M
4
Citadel Advisors
Citadel Advisors
Florida
-$28.3M
5
SAM
Sectoral Asset Management
Quebec, Canada
-$27.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Holocene Advisors
51
Holocene Advisors
New York
$3.56M -$39.8M -1,202,128 -92%
Wells Fargo
52
Wells Fargo
California
$3.47M +$1M +30,279 +45%
Deutsche Bank
53
Deutsche Bank
Germany
$3.42M +$1.39M +41,909 +78%
SEI Investments
54
SEI Investments
Pennsylvania
$3.06M +$2.02M +61,029 +183%
FAM
55
Fred Alger Management
New York
$3.04M -$35.5K -1,073 -1%
CIBC Private Wealth Group
56
CIBC Private Wealth Group
Georgia
$2.77M +$2.57M +77,710 New
B
57
Bailard
California
$2.6M +$2.42M +72,938 New
UBS Group
58
UBS Group
Switzerland
$2.5M +$1.14M +34,423 +96%
RI
59
RTW Investments
New York
$2.5M – – –
CAM
60
ClariVest Asset Management
California
$2.35M +$2.19M +66,054 New
ACI
61
AMP Capital Investors
Australia
$2.29M +$386K +11,658 +22%
RhumbLine Advisers
62
RhumbLine Advisers
Massachusetts
$2.28M +$2.12M +63,863 New
CSS
63
Cubist Systematic Strategies
Connecticut
$2.26M -$477K -14,395 -19%
Bank of America
64
Bank of America
North Carolina
$2.16M -$1.09M -32,885 -35%
ECM
65
Endurant Capital Management
California
$2.07M +$1.93M +58,168 New
Two Sigma Advisers
66
Two Sigma Advisers
New York
$2.05M +$19.9K +600 +1%
Qube Research & Technologies (QRT)
67
Qube Research & Technologies (QRT)
United Kingdom
$1.67M +$1.23M +37,085 +380%
New York State Common Retirement Fund
68
New York State Common Retirement Fund
New York
$1.6M +$1.48M +44,800 New
Susquehanna International Group
69
Susquehanna International Group
Pennsylvania
$1.55M +$1.44M +43,499 New
SSA
70
Schonfeld Strategic Advisors
New York
$1.49M +$696K +21,005 +101%
Baird Financial Group
71
Baird Financial Group
Wisconsin
$1.37M +$1.27M +38,376 New
Ohio Public Employees Retirement System (OPERS)
72
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.27M +$1.18M +35,674 New
AllianceBernstein
73
AllianceBernstein
Tennessee
$1.25M +$1.16M +35,060 New
ZP
74
Zimmer Partners
New York
$1.14M – – –
MAM
75
Myriad Asset Management
Hong Kong
$1.14M +$1.06M +32,000 New
1 2
3
4 5

MRVI Hedge Fund Activity: Q1 2021 in Review

144 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Maravai LifeSciences (MRVI) for Q1 2021, worth a combined $3.51B — up 28% from $2.73B a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new MRVI positions and 30 closed out — a net gain of 26 holders — while 41 added to existing stakes and 34 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $132M. The largest seller was D1 Capital Partners, exiting entirely with an estimated $166M sold.

  • 144 institutional investors held Maravai LifeSciences (MRVI) as of Q1 2021, up from 118 in Q4 2020.
  • Funds reported $3.51B of Maravai LifeSciences stock for Q1 2021, up 28% quarter-over-quarter.
  • 56 funds opened new Maravai LifeSciences positions in Q1 2021 and 30 closed out, a net change of +26 holders.
  • The largest Maravai LifeSciences buyer in Q1 2021 was Fidelity Investments, an estimated $132M added.
  • The largest Maravai LifeSciences seller in Q1 2021 was D1 Capital Partners, an estimated $166M sold.

Based on aggregated 13F filings for Q1 2021.